NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
Zhang L, Li R, Shi W, Liang X, Liu S, Ye Z, Yu C, Chen Y, Zhang B, Wang W, Lai Y, Ma J, Li Z, Tan X.
Zhang L, et al.
Br J Pharmacol. 2013 Sep;170(2):426-39. doi: 10.1111/bph.12292.
Br J Pharmacol. 2013.
PMID: 23826864
Free PMC article.